Whole grain in metabolic syndrome
- Conditions
- Metabolic Syndrome.Metabolic disorder, unspecified
- Registration Number
- IRCT20160111025947N2
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
1)Abdominal obesity as defined as a waist circumference in women =80 cm and in men =94 cm based on the cutoff measurements of the Middle East (31)
2)Serum triglycerides =150 mg/dl (1.7mmol/l)
3)Serum high-density lipoprotein (HDL) cholesterol <40 mg/dl (1 mmol/L) in men and <50 mg/dl (1.3 mmol/l) in women
4)Blood pressure =130/85 mmHg
5)Fasting plasma glucose (FPG) between 100-125mg/dl (5.6-6.9) mmol/l
6) 25-64 years old
•Individuals with a history of diabetes,
Individuals with a history of cardiovascular diseases,
Individuals with a history of cancer,
Individuals with a history of kidney disease,
Individuals with a history of lower gastrointestinal conditions
Individuals with a history of celiac disease.•
Individuals taking medications which could influence lipid metabolism except for low- intensity Statin therapy,
Individuals taking medications which could influence glucose metabolism except for Metformin up to 1000mg/day
Individuals taking medications which could influence blood pressuer except for losartan up to 25mg/day
Women who are pregnant or may become pregnant during the duration of the study
breast-feeding women
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fasting blood sugar. Timepoint: before intervention and 3,4,7 months after intervention. Method of measurement: by Glucose oxidase method.
- Secondary Outcome Measures
Name Time Method